DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Apollo Hospitals Enterprise Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·15 Oct 2026, 11:46 am

Apollo Hospitals Enter. L

Apollo Hospitals Enterprise Limited has announced the schedule for its upcoming meeting with analysts and institutional investors. This event is a standard corporate practice where the company management outlines its business strategy and performance outlook to the financial community.

For investors, this update is significant as it provides a platform for management to address market expectations and share future plans. It helps clarify the company's direction, which can be crucial for understanding potential growth drivers and operational challenges ahead.

Investors should watch for any specific guidance provided by management regarding revenue targets, expansion plans, or profitability. This information will be key to assessing the company's short-term and long-term prospects.